INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 155 filers reported holding INARI MED INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $75,631,241 | +9.4% | 1,156,441 | -2.7% | 0.08% | +13.2% |
| Q2 2023 | $69,126,483 | -3.4% | 1,188,966 | +2.6% | 0.07% | -5.6% |
| Q1 2023 | $71,544,127 | +40.5% | 1,158,797 | +44.7% | 0.07% | +33.3% |
| Q4 2022 | $50,908,636 | +27.3% | 800,954 | +45.5% | 0.05% | +20.0% |
| Q3 2022 | $39,979,000 | +7.4% | 550,370 | +0.5% | 0.04% | +15.4% |
| Q2 2022 | $37,239,000 | -22.3% | 547,725 | +3.6% | 0.04% | -4.9% |
| Q1 2022 | $47,904,000 | -22.3% | 528,507 | -21.8% | 0.04% | +24.2% |
| Q4 2021 | $61,657,000 | +20.9% | 675,546 | +7.5% | 0.03% | +17.9% |
| Q3 2021 | $50,981,000 | -14.2% | 628,618 | -1.3% | 0.03% | -9.7% |
| Q2 2021 | $59,415,000 | +80.5% | 636,963 | +107.1% | 0.03% | +82.4% |
| Q1 2021 | $32,909,000 | +612.5% | 307,558 | +481.3% | 0.02% | +750.0% |
| Q4 2020 | $4,619,000 | – | 52,907 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 125,000 | $11,409,000 | 4.14% |
| SECTORAL ASSET MANAGEMENT INC | 163,550 | $14,927,000 | 2.25% |
| Lisanti Capital Growth, LLC | 81,460 | $7,435,000 | 1.08% |
| Pier Capital, LLC | 99,422 | $9,074,000 | 0.96% |
| Beck Bode, LLC | 33,384 | $3,047,000 | 0.76% |
| Nicholas Investment Partners, LP | 104,932 | $9,577,000 | 0.61% |
| CNA FINANCIAL CORP | 24,773 | $2,261,000 | 0.59% |
| NEXT CENTURY GROWTH INVESTORS LLC | 56,523 | $5,158,000 | 0.46% |
| HARBOURVEST PARTNERS LLC | 38,540 | $3,518,000 | 0.45% |
| Birchview Capital, LP | 7,000 | $639,000 | 0.41% |